期刊文献+

单向白蛋白透析滤过对模拟肝衰竭患者血浆的净化作用 被引量:2

The study of the purification function of single-pass albumin diafiltration(SPADF) in vitro
下载PDF
导出
摘要 目的:观察单向白蛋白透析滤过技术对模拟肝衰竭患者血浆的净化作用。方法:利用单向白蛋白透析滤过或持续性静-静脉血液透析滤过处理含有一定浓度代谢产物的血浆,检测治疗前后血浆中胆红素,胆汁酸,氨,尿素和肌酐浓度,并利用SPSS 10.0软件进行统计学分析。结果:单向白蛋白透析滤过可显著降低血浆胆红素水平,而持续性静-静脉血液透析滤过对胆红素水平无显著影响。胆汁酸的降低幅度在单向白蛋白透析滤过组显著高于持续性静-静脉血液透析滤过组。两种方法对水溶性代谢产物氨、尿素和肌酐的清除作用相似。结论:单向白蛋白透析滤过清除血浆中白蛋白结合物质的作用强于持续性静-静脉血液透析滤过,对水溶性物质的清除,二者作用相似。 Aim:To evaluate the detoxication capacities of single-pass albumin diafiltration (SPADF) in vitro. Methods: In each experiment quantitative toxin-loaded human plasma was processed by SPADF or CVVHDF. levels of bilirubin, bile acids, ammonia, urea and creatinine were determined. Concentrations before and after application of detoxication procedures were expressed as differences and were compared using the SPSS 10. 0 software. Results: SPADF induced a significant reduction in bilirubin levels than CVVHDF. SPADF induced a signicanfly reduction of bile acid levels than CVVHDF. No significant differences were found between SPADF and CVVHDF with respect to other water-soluble substances. Conclusion: The detoxication capacity of SPADF for albumin-bounding substances is stronger than that of CVVHDF.
出处 《暨南大学学报(自然科学与医学版)》 CAS CSCD 北大核心 2007年第2期160-163,共4页 Journal of Jinan University(Natural Science & Medicine Edition)
基金 广东省科学技术厅-广东省粤港地区重大领域项目招投标(2005A11304005)
关键词 白蛋白透析滤过 肝衰竭 人工 albumin diafiltration liver failure liver artificial
  • 相关文献

参考文献7

  • 1GREGORY J,QUINLAN,GREG S,et al.Albumin:biochemical properties and therapeutic potential[J].Hepatology,2005,41(6):1211-1219.
  • 2SEN S,JALAN R,WILLIAMS R.Liver failure:basis of benefit of therapy with the molecular adsorbents recirculating system[J].Int J Biochem Cell Biol,2003,35:1306-1311.
  • 3STEINER C,MITZNER S.Experiences with MARS liver support therapy in liver failure:analysis of 176 patients of the International MARS Registry[J].Liver,2002,22(Suppl 2):20-25.
  • 4MITZNER S,LOOCK J,PESZYNKSI P,et al.Improvement in central nervous system functions during treatment of liver failure with albumin dialysis MARS:a review of clinical,biochemical,and electrophysiological data[J].Metab Brain Dis,2002,17:463-475.
  • 5吴赤红,徐小元,陆海英.分子吸附循环系统治疗重型肝炎肝功能衰竭的临床研究[J].中国急救医学,2004,24(10):710-712. 被引量:3
  • 6陈士彬,张伦理,史宇飞,杨小兰,王芝花.分子吸附循环系统治疗肝衰竭52例[J].中华肝脏病杂志,2004,12(3):131-133. 被引量:8
  • 7ARTTU LAHDENPERA,ANNA-MARIA KOIVUSALO,ANNE VAKKURI,et al.Value of albumin dialysis therapy in severe liver insufficiency[J].Transplantation International,2005,17:717-723.

二级参考文献11

  • 1[1]Mitzner SR, Stange J, Klammt S, et al. Extracorporeal detocification using the moleculr adsorbents recirculating system for critically ill patients with liver failure[J]. J Am Soc Neprol,2001,12(suppl 17):S 75- S 82.
  • 2[3]Stange J, Mitzner SR, Risler T, et al . Molecular adsorbents recirculating system( MARS ): Clinical results of a new membrane - based blood purification system for bioartificial liver support[J]. Artif Organs, 1999,23:319 - 330.
  • 3[4]Schmidt LE, Serensen VR, Svendsen LB, et al . Hemodynamic changes during a single treatment with the molecular adsorbents recirculating system in patients with acute -on -chronic liver failure [J]. Liver Transpl,2001,7:1034 - 1039.
  • 4[5]Schmidt LE, Svendsen LB, Sorensen VR, et al . Cerebral blood flow velocity increases during a single treatment with the molecular adsorbents recirculating system in patients with acute - on - chronic liver failure [J] .Liver Transpl,2001,7:709 - 712.
  • 5[6]Sorkine P, Ben Alahamk, Szold O, et al . Role of the molecular adsorbents recirculating system in the treatment of patients with acute exacerbation of chronic liver failure [J]. Crit Care Med, 2001,29: 1332- 1336.
  • 6Schmidt LE, Sorensen VR, Svendsen LB, et al. Hemodynamic changes during a single treatment with the molecular adsorbents recirulating system in patients with acute-on-chronic liver failure. Liver transpl,2001, 7: 1034-1039.
  • 7Ben Abraham R, Szold O, Merhav H, et al. Rapid resolution of brain edema and improved cerebral perfusion pressure following the molecular adsorbent recycling system in acute liver failure patients.Transplant Proc, 2001, 33: 2897-2899.
  • 8Mitzner SR, Stange J, Klammt S, et al. Extracoporeal detoxification using the molecular adsorbents recirculating system for critically ill patients with liver failure. J Am Soc Nephrol, 2001, 12(Suppl 17):75-82.
  • 9Stange J, Hassanein TI,Mehta R,et al. The molecular adsorbents recycling system as a liver support system based on albumin dialysis:a summary of preclinical investigations, prospective, randomized,controlled clinical trial, and clinical experience from 19
  • 10Williams R,Wendon J. Indications for orthotopic liver transplantation in fulminant liver failure. Hepatology, 1994, 20(pt 2): S5-S10.

共引文献9

同被引文献19

  • 1龚晓兵,杨冬华,杨见权,韦宏成.体外比较单向白蛋白透析滤过与分子吸附循环系统的血液净化作用[J].广东医学,2006,27(11):1636-1637. 被引量:2
  • 2Arora G, Keeffe EB. Management of chronic liver failure until liver transplantation [ J]. Med Clin North Am, 2008, 92 (4) : 839 -860.
  • 3Gregory J, Quinlan GS. Martin TW. Evans. Albumin: Biochemical properties and therapeutic potential[ J]. Hepatology, 2005,41 (6) : 1211 -1219.
  • 4Sen S, Jalan R, Williams R. Liver failure : Basis of benefit of therapy with the molecular adsorbents recirculating system[ J]. Int J Biochem Cell Biol, 2003, 35: 1306- 1311.
  • 5Novelli G, Rossi M, Pugliese F, et al. Molecular adsorbents recirculating system treatment in acute-on-chronic hepatitis patients on the transplant waiting list improves model for end-stage liver disease scores[ J]. Transplant Proc, 2007, 39 (6) : 1864 - 1867.
  • 6Novelli G, Rossi M, Morabito V, et al. Pediatric acute liver failure with molecular adsorbents recirculating system treatment[J]. Transplant Proc, 2008, 40(6) : 1921 -1924.
  • 7Hu XB, Zhou Y, Zhao YQ, et al. Therapeutic application of molecular adsorbents recirculating system (MARS) in chronic severe hepatitis patients complicated with multiorgan failure [ J ]. J Gastrointestinal Surg, 2005, 9 (4) : 599.
  • 8刘翠萍,余祖江.全程门冬氨酸鸟氨酸治疗延缓乙型肝炎病毒相关慢加急性肝衰竭的进展[J].中华肝脏病杂志,2011,19(1):63-64. 被引量:16
  • 9张文瑾,范振平,蔡少平,吉英杰,高峰,罗生强,张海燕.青中老年肝衰竭的发病率和病因分析[J].医学临床研究,2011,28(1):157-158. 被引量:2
  • 10朱燕波.中医体质分类判定与兼夹体质的综合评价[J].中华中医药杂志,2012,27(1):37-39. 被引量:89

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部